GH/STAT5 signaling during the growth period in livers of mice overexpressing GH

Journal of Molecular Endocrinology

Volumn 54, Issue 2, 2015, Pages 171-184

  Martinez, Carolina S ^a   Piazza, Verónica G ^a   Díaz, María E ^a   Boparai, Ravneet K ^b   Arum, Oge ^b   Ramírez, María C ^c   González, Lorena ^a   Becú Villalobos, Damasia ^c   Bartke, Andrzej ^b   Turyn, Daniel ^a   Miquet, Johanna G ^a   Sotelo, Ana I ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INST DE BIOL Y MED EXPERIMENTAL   (Argentina)

Author keywords

GH signaling; GH overexpressing mice; Growth; Liver; STAT5

Indexed keywords

COMPLEMENTARY DNA; GROWTH HORMONE; MESSENGER RNA; RNA; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BODY SIZE; BODY WEIGHT; GENE EXPRESSION ASSAY; IMMUNOBLOTTING; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHOSPHORYLATION;

ANIMALS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LIVER; MICE, INBRED C57BL; MICE, TRANSGENIC; PHOSPHORYLATION; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84929072983     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0262     Document Type: Article

References (65)

1. Adams TE, Hansen JA, Starr R, Nicola NA, Hilton DJ & Billestrup N 1998 Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. Journal of Biological Chemistry 273 1285-1287. (doi:10.1074/jbc.273.3.1285)
2. Barclay JL, Kerr LM, Arthur L, Rowland JE, Nelson CN, Ishikawa M, d’Aniello EM, White M, Noakes PG & Waters MJ 2010 In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2. Molecular Endocrinology 24 204-217. (doi:10.1210/me.2009-0233)
3. Barclay JL, Nelson CN, Ishikawa M, Murray LA, Kerr LM, McPhee TR, Powell EE & Waters MJ 2011 GH-dependent STAT5 signaling plays an important role in hepatic lipid metabolism. Endocrinology 152 181-192. (doi:10.1210/en.2010-0537)
4. Bielohuby M, Schaab M, Kummann M, Sawitzky M, Gebhardt R, Binder G, Frystyk J, Bjerre M, Hoeflich A, Kratzsch J et al. 2011 SerumIGF-I is not a reliablepharmacodynamicmarkerof exogenousgrowthhormone activity in mice. Endocrinology 152 4764-4776. (doi:10.1210/en.2011-1432)
5. Brooks AJ & Waters MJ 2010 The growth hormone receptor: mechanism of activation and clinical implications. Nature Reviews. Endocrinology 6 515-525. (doi:10.1038/nrendo.2010.123)
6. Chen Y, Lin G, Huo JS, Barney D, Wang Z, Livshiz T, States DJ, Qin ZS & Schwartz J 2009 Computational and functional analysis of growth hormone (GH)-regulated genes identifies the transcriptional repressor B-cell lymphoma 6 (Bc16) as a participant in GH-regulated transcription. Endocrinology 150 3645-3654. (doi:10.1210/en.2009-0212)
7. Croker BA, Kiu H & Nicholson SE 2008 SOCS regulation of the JAK/STAT signalling pathway. Seminars in Cell & Developmental Biology 19 414-422. (doi:10.1016/j.semcdb.2008.07.010)
8. Eleswarapu S & Jiang H 2005 Growth hormone regulates the expression of hepatocyte nuclear factor-3 gamma and other liver-enriched transcription factors in the bovine liver. Journal of Endocrinology 184 95-105. (doi:10.1677/joe.1.05821)
9. Engblom D, Kornfeld JW, Schwake L, Tronche F, Reimann A, Beug H, Hennighausen L, Moriggl R & Schutz G 2007 Direct glucocorticoid receptor-Stat5 interaction in hepatocytes controls body size and maturation-related gene expression. Genes and Development 21 1157-1162. (doi:10.1101/gad.426007)
10. Fan Y, Menon RK, Cohen P, Hwang D, Clemens T, DiGirolamo DJ, Kopchick JJ, Le Roith D, Trucco M & Sperling MA 2009 Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. Journal of Biological Chemistry 284 19937-19944. (doi:10.1074/jbc.M109.014308)
11. Flores-Morales A, Greenhalgh CJ, Norstedt G & Rico-Bautista E 2006 Negative regulation of growth hormone receptor signaling. Molecular Endocrinology 20 241-253. (doi:10.1210/me.2005-0170)
12. Friedbichler K, Themanns M, Mueller KM, Schlederer M, Kornfeld JW, Terracciano LM, Kozlov AV, Haindl S, Kenner L, Kolbe T et al. 2012 Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancer. Hepatology 55 941-952. (doi:10.1002/hep.24765)
13. Gonzalez L, Miquet JG, Sotelo AI, Bartke A & Turyn D 2002 Cytokineinducible SH2 protein up-regulation is associated with desensitization of GH signaling in GHRH-transgenic mice. Endocrinology 143 386-394. (doi:10.1210/endo.143.2.8616)
14. Gonzalez L, Curto LM, Miquet JG, Bartke A, Turyn D & Sotelo AI 2007 Differential regulation of membrane associated-growth hormone binding protein (MA-GHBP) and growth hormone receptor (GHR) expression by growth hormone (GH) in mouse liver. Growth Hormone & IGF Research 17 104-112. (doi:10.1016/j.ghir.2006.12.002)
15. Hyatt MA, Walker DA, Stephenson T & Symonds ME 2004 Ontogeny and nutritional manipulation of the hepatic prolactin-growth hormoneinsulin- like growth factor axis in the ovine fetus and in neonate and juvenile sheep. Proceedings of the Nutrition Society 63 127-135. (doi:10.1079/PNS2003324)
16. Iida K, Del Rincon JP, Kim DS, Itoh E, Nass R, Coschigano KT, Kopchick JJ & Thorner MO 2004 Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit)mice and transgenicmice that overexpress bovine GH (bGH) or a bGH antagonist. Endocrinology 145 1564-1570. (doi:10.1210/en.2003-1486)
17. Inagaki T, Lin VY, Goetz R, Mohammadi M, Mangelsdorf DJ & Kliewer SA 2008 Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metabolism 8 77-83. (doi:10.1016/j.cmet.2008.05.006)
18. Jiang H, Wang Y, Wu M, Gu Z, Frank SJ & Torres-Diaz R 2007 Growth hormone stimulates hepatic expression of bovine growth hormone receptor messenger ribonucleic acid through signal transducer and activator of transcription 5 activation of a major growth hormone receptor gene promoter. Endocrinology 148 3307-3315. (doi:10.1210/en.2006-1738)
19. Kaplan SA & Cohen P 2007 The somatomedin hypothesis 2007: 50 years later. Journal of Clinical Endocrinology and Metabolism 92 4529-4535. (doi:10.1210/jc.2007-0526)
20. Kile BT, Schulman BA, Alexander WS, Nicola NA, Martin HM & Hilton DJ 2002 The SOCS box: a tale of destruction and degradation. Trends in Biochemical Sciences 27 235-241. (doi:10.1016/S0968-0004(02)02085-6)
21. Kliewer SA & Mangelsdorf DJ 2010 Fibroblast growth factor 21: from pharmacology to physiology. American Journal of Clinical Nutrition 91 254S-257S. (doi:10.3945/ajcn.2009.28449B)
22. Klover P & Hennighausen L 2007 Postnatal body growth is dependent on the transcription factors signal transducers and activators of transcription 5a/b in muscle: a role for autocrine/paracrine insulin-like growth factor I. Endocrinology 148 1489-1497. (doi:10.1210/en.2006-1431)
23. Kornfeld JW, Grebien F, Kerenyi MA, Friedbichler K, Kovacic B, Zankl B, Hoelbl A, Nivarti H, Beug H, Sexl V et al. 2008 The different functions of Stat5 and chromatin alteration through Stat5 proteins. Frontiers in Bioscience 13 6237-6254. (doi:10.2741/3151)
24. Kubicky RA, Wu S, Kharitonenkov A & De Luca F 2012 Role of fibroblast growth factor 21 (FGF21) in undernutrition-related attenuation of growth in mice. Endocrinology 153 2287-2295. (doi:10.1210/en.2011-1909)
25. Lahuna O, Rastegar M, Maiter D, Thissen JP, Lemaigre FP & Rousseau GG 2000 Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone. Molecular Endocrinology 14 285-294. (doi:10.1210/mend.14.2.0423)
26. Landsman T & Waxman DJ 2005 Role of the cytokine-induced SH2 domain-containing protein CIS in growth hormone receptor internalization. Journal of Biological Chemistry 280 37471-37480. (doi:10.1074/jbc.M504125200)
27. Lanning NJ & Carter-Su C 2006 Recent advances in growth hormone signaling. Reviews in Endocrine & Metabolic Disorders 7 225-235. (doi:10.1007/s11154-007-9025-5)
28. Lee YH, Sauer B & Gonzalez FJ 1998 Laron dwarfism and non-insulindependent diabetes mellitus in the Hnf-1a knockout mouse. Molecular and Cellular Biology 18 3059-3068.
29. Lin WY, Hu YJ & Lee YH 2008 Hepatocyte nuclear factor-1a regulates glucocorticoid receptor expression to control postnatal body growth. American Journal of Physiology. Gastrointestinal and Liver Physiology 295 G542-G551. (doi:10.1152/ajpgi.00081.2008)
30. Linossi EM & Nicholson SE 2012 The SOCS box-adapting proteins for ubiquitination and proteasomal degradation. IUBMB Life 64 316-323. (doi:10.1002/iub.1011)
31. List EO, Berryman DE, Funk K, Jara A, Kelder B, Wang F, Stout MB, Zhi X, Sun L, White TA et al. 2014 Liver-specific GH receptor gene disrupted (LiGHRKO) mice have decreased endocrine IGF-1, increased local IGF-1 as well as altered body size, body composition and adipokine profiles. Endocrinology 155 1793-1805. (doi:10.1210/en.2013-2086)
32. Liu JL & LeRoith D 1999 Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 140 5178-5184. (doi:10.1210/endo.140.11.7151)
33. Lupu F, Terwilliger JD, Lee K, Segre GV & Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Developmental Biology 229 141-162. (doi:10.1006/dbio.2000.9975)
34. Maes M, De Hertogh R, Watrin-Granger P & Ketelslegers JM 1983 Ontogeny of liver somatotropic and lactogenic binding sites in male and female rats. Endocrinology 113 1325-1332. (doi:10.1210/endo-113-4-1325)
35. Maiter D, Underwood LE, Maes M, Davenport ML & Ketelslegers JM 1988 Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 123 1053-1059. (doi:10.1210/endo-123-2-1053)
36. Martinez CS, Piazza VG, Ratner LD, Matos MN, Gonzalez L, Rulli SB, Miquet JG & Sotelo AI 2013 Growth hormone STAT5-mediated signaling and its modulation in mice liver during the growth period. Growth Hormone & IGF Research 23 19-28. (doi:10.1016/j.ghir.2012.11.002)
37. Mathews LS, Hammer RE, Brinster RL & Palmiter RD 1988 Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 123 433-437. (doi:10.1210/endo-123-1-433)
38. Mathews LS, Enberg B & Norstedt G 1989 Regulation of rat growth hormone receptor gene expression. Journal of Biological Chemistry 264 9905-9910.
39. McGrane MM, Yun JS, Moorman AF, Lamers WH, Hendrick GK, Arafah BM, Park EA, Wagner TE & Hanson RW 1990 Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. Journal of Biological Chemistry 265 22371-22379.
40. Meyer RD, Laz EV, Su T & Waxman DJ 2009 Male-specific hepatic Bcl6: growth hormone-induced block of transcription elongation in females and binding to target genes inversely coordinated with STAT5. Molecular Endocrinology 23 1914-1926. (doi:10.1210/me.2009-0242)
41. Miquet JG, Sotelo AI, Bartke A & Turyn D 2004 Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH. Endocrinology 145 2824-2832. (doi:10.1210/en.2003-1498)
42. Miquet JG, Freund T, Martinez CS, Gonzalez L, Diaz ME, Micucci GP, Zotta E, Boparai RK, Bartke A, Turyn D et al. 2013 Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone. Cell Cycle 12 1042-1057. (doi:10.4161/cc.24026)
43. Mueller KM, Kornfeld JW, Friedbichler K, Blaas L, Egger G, Esterbauer H, Hasselblatt P, Schlederer M, Haindl S, Wagner KU et al. 2011 Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice. Hepatology 54 1398-1409. (doi:10.1002/hep.24509)
44. Mueller KM, Themanns M, Friedbichler K, Kornfeld JW, Esterbauer H, Tuckermann JP & Moriggl R 2012 Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development. Molecular and Cellular Endocrinology 361 1-11. (doi:10.1016/j.mce.2012.03.026)
45. Piessevaux J, Lavens D, Montoye T, Wauman J, Catteeuw D, Vandekerckhove J, Belsham D, Peelman F & Tavernier J 2006 Functional crossmodulation between SOCS proteins can stimulate cytokine signaling. Journal of Biological Chemistry 281 32953-32966. (doi:10.1074/jbc.M600776200)
46. Pilecka I, Patrignani C, Pescini R, Curchod ML, Perrin D, Xue Y, Yasenchak J, Clark A, Magnone MC, Zaratin P et al. 2007 Protein-tyrosine phosphatase H1 controls growth hormone receptor signaling and systemic growth. Journal of Biological Chemistry 282 35405-35415. (doi:10.1074/jbc.M705814200)
47. Ramirez MC, Luque GM, Ornstein AM & Becu-Villalobos D 2010 Differential neonatal testosterone imprinting of GH-dependent liver proteins and genes in female mice. Journal of Endocrinology 207 301-308. (doi:10.1677/JOE-10-0276)
48. Rastegar M, Lemaigre FP & Rousseau GG 2000 Control of gene expression by growth hormone in liver: key role of a network of transcription factors. Molecular and Cellular Endocrinology 164 1-4. (doi:10.1016/S0303-7207(00)00263-X)
49. Rotwein P 2012 Mapping the growth hormone-Stat5b-IGF-I transcriptional circuit. Trends in Endocrinology and Metabolism 23 186-193. (doi:10.1016/j.tem.2012.01.001)
50. Sedek M, van der Velden LM & Strous GJ 2014 Multimeric growth hormone receptor complexes serve as signaling platforms. Journal of Biological Chemistry 289 65-73. (doi:10.1074/jbc.M113.523373)
51. Shi SY, Martin RG, Duncan RE, Choi D, Lu SY, Schroer SA, Cai EP, Luk CT, Hopperton KE, Domenichiello AF et al. 2012 Hepatocyte-specific deletion of Janus kinase 2 (JAK2) protects against diet-induced steatohepatitis and glucose intolerance. Journal of Biological Chemistry 287 10277-10288. (doi:10.1074/jbc.M111.317453)
52. Sotelo AI, Miquet JG, Gonzalez L, Bartke A & Turyn D 2008 Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5- signaling in GH-overexpressing mice non-calcemic tissues. Growth Hormone & IGF Research 18 148-156. (doi:10.1016/j.ghir.2007.08.001)
53. Tang Z, Yu R, Lu Y, Parlow AF & Liu JL 2005 Age-dependent onset of liverspecific IGF-I gene deficiency and its persistence in old age: implications for postnatal growth and insulin resistance in LID mice. American Journal of Physiology. Endocrinology and Metabolism 289 E288-E295. (doi:10.1152/ajpendo.00494.2004)
54. Tannahill GM, Elliott J, Barry AC, Hibbert L, Cacalano NA & Johnston JA 2005 SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Molecular and Cellular Biology 25 9115-9126. (doi:10.1128/MCB.25.20.9115-9126.2005)
55. Thangavel C & Shapiro BH 2007 A molecular basis for the sexually dimorphic response to growth hormone. Endocrinology 148 2894-2903. (doi:10.1210/en.2006-1333)
56. Tollet-Egnell P, Flores-Morales A, Stavreus-Evers A, Sahlin L & Norstedt G 1999 Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140 3693-3704. (doi:10.1210/endo.140.8.6878)
57. Torre C, Benhamouche S, Mitchell C, Godard C, Veber P, Letourneur F, Cagnard N, Jacques S, Finzi L, Perret C et al. 2011 The transforming growth factor-a and cyclin D1 genes are direct targets of b-catenin signaling in hepatocyte proliferation. Journal of Hepatology 55 86-95. (doi:10.1016/j.jhep.2010.10.021)
58. Tronche F, Opherk C, Moriggl R, Kellendonk C, Reimann A, Schwake L, Reichardt HM, Stangl K, Gau D, Hoeflich A et al. 2004 Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth. Genes and Development 18 492-497. (doi:10.1101/gad.284704)
59. Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S & Chretien S 1998 A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Molecular and Cellular Biology 18 5852-5860.
60. Vesterlund M, Zadjali F, Persson T, Nielsen ML, Kessler BM, Norstedt G & Flores-Morales A 2011 The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS ONE 6 e25358. (doi:10.1371/journal.pone.0025358)
61. Welinder C & Ekblad L 2011 Coomassie staining as loading control in western blot analysis. Journal of Proteome Research 10 1416-1419. (doi:10.1021/pr1011476)
62. Woelfle J, Billiard J & Rotwein P 2003 Acute control of insulin-like growth factor-I gene transcription by growth hormone through Stat5b. Journal of Biological Chemistry 278 22696-22702. (doi:10.1074/jbc.M301362200)
63. Yu J, Zhao L, Wang A, Eleswarapu S, Ge X, Chen D & Jiang H 2012 Growth hormone stimulates transcription of the fibroblast growth factor 21 gene in the liver through the signal transducer and activator of transcription 5. Endocrinology 153 750-758. (doi:10.1210/en.2011-1591)
64. Zhang Y, Guan R, Jiang J, Kopchick JJ, Black RA, Baumann G & Frank SJ 2001 Growth hormone (GH)-induced dimerization inhibits phorbol ester-stimulated GH receptor proteolysis. Journal of Biological Chemistry 276 24565-24573. (doi:10.1074/jbc.M101281200)
65. Zhang Y, Laz EV & Waxman DJ 2012 Dynamic, sex-differential STAT5 and BCL6 binding to sex-biased, growth hormone-regulated genes in adult mouse liver. Molecular and Cellular Biology 32 880-896. (doi:10.1128/MCB.06312-11)